BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T170000
DTEND;TZID=America/Los_Angeles:20260910T190000
DTSTAMP:20260810T212922Z
CREATED:20260810T212922Z
LAST-MODIFIED:20260810T212922Z
UID:10001151-1789059600-1789066800@www.califesciences.org
SUMMARY:MedTech CEO Networking Reception
DESCRIPTION:Designed exclusively for manufacturing company CEOs and senior executives\, these intimate events provide an opportunity to briefly step away from day-to-day demands and engage with peers on the timely and relevant issues facing you and your company and shaping the future of our industry. \nWhat you’ll gain: \n\nConnect with fellow medtech leaders in a small\, invitation-only setting designed to foster candid conversations and valuable new relationships.\nHear unfiltered insights from industry CEOs as they discuss the opportunities\, challenges\, and strategic decisions keeping leadership teams focused today—from innovation and growth to policy\, investment\, talent\, board management\, the impact of AI and the evolving healthcare landscape.\nGet an exclusive and brief preview of The MedTech Conference\, including opportunities designed specifically for CEOs and executive leadership\, while helping shape the conversations that will continue in Boston this October.\n\nThe program will feature a discussion with: \n\nQuentin Blackford\, President & Chief Executive Officer\, iRhythm \nLisa Earnhardt\, EVP and Group President\, Medical Devices\, Abbott\nModerator: Philip Oettinger\, Partner\, Wilson Sonsini \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/medtech-ceo-networking-reception/
LOCATION:Wilson Sonsini\, One Market Plaza Spear Tower\, 19th Floor\, San Francisco\, CA\, 94105\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T160000
DTEND;TZID=America/Los_Angeles:20260910T180000
DTSTAMP:20260903T215900Z
CREATED:20260903T215900Z
LAST-MODIFIED:20260903T215900Z
UID:10001188-1789056000-1789063200@www.califesciences.org
SUMMARY:Lab 2 Lounge
DESCRIPTION:You’re invited to a fun and unique event. Come by Salt & Brine at Alexandria Center for Life Sciences for “Lab 2 Lounge\,” a happy hour event where you can enjoy tasty appetizers\, beer & wine\, and good music with a LIVE DJ. \nSee the latest life science products and technologies from leading suppliers and network with colleagues and industry professionals. No cost to attend this fun community event. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lab-2-lounge/
LOCATION:Salt & Brine\, 835 Industrial Road\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T160000
DTEND;TZID=America/Los_Angeles:20260910T173000
DTSTAMP:20260824T161626Z
CREATED:20260824T161601Z
LAST-MODIFIED:20260824T161626Z
UID:10001172-1789056000-1789061400@www.califesciences.org
SUMMARY:Entity Choice Selection
DESCRIPTION:A practical\, no-jargon session breaking down C-Corps\, LLCs\, Partnerships\, and Sole Proprietorships — so founders can choose the entity that actually fits their liability needs\, tax situation\, and growth plans. We’ll cover the real trade-offs. \n\nC-Corporation\nPartnership\nLLC\nSole Proprietorship\nPros / Cons\n\nLiability protection\nSelf-employment tax\nEntity-level tax\nGood for investors\nExit strategy\n\n\nTax Filing Requirements and due dates\nSalaries treatment & deferred compensation\nValuation questions\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/entity-choice-selection/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260910T140000
DTEND;TZID=America/New_York:20260910T150000
DTSTAMP:20260820T211414Z
CREATED:20260820T211352Z
LAST-MODIFIED:20260820T211414Z
UID:10001162-1789048800-1789052400@www.califesciences.org
SUMMARY:The Insider's Guide to Leveraging Podcasts\, Webinars and Thought Leadership Programs
DESCRIPTION:How do you turn podcasts\, webinars and thought leadership programs into meaningful visibility for your organization or clients? \nJoin BioSpace’s Managing Editor\, Director of Insights and Vice President of Marketing for an inside look at how PR\, communications and marketing teams can successfully leverage webinars\, podcasts and integrated content campaigns to elevate executive voices\, share industry expertise and engage key biotech and pharma audiences. \nIn this interactive discussion\, our team will break down the differences between available thought leadership opportunities\, explain how content is selected and developed\, and share what makes a pitch stand out. You’ll gain practical guidance on identifying the right opportunities\, aligning topics with our audience interests\, preparing speakers for successful appearances and maximizing the value of participation before\, during and after an event. \nWhether you’re promoting an executive thought leader\, launching a new initiative or building long-term brand awareness\, you’ll walk away with actionable tips to help secure stronger opportunities and better outcomes. Attendees will also have the opportunity to ask questions during a live Q&A with the BioSpace editorial\, insights and marketing teams. \nWhat to expect: \n\nGain strong practical understanding of how BioSpace podcasts and webinars are developed\, produced and marketed\nGet an insider’s perspective on what makes a guest\, topic or pitch stand out to our team\nDiscover how to identify thought leadership opportunities that align with your marketing and communications goals\nLearn how to prepare executives for stronger\, more engaging appearances\nGet practical tips for extending the reach and impact of your content before\, during and after an event\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T100000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260824T160958Z
CREATED:20260824T160958Z
LAST-MODIFIED:20260824T160958Z
UID:10001171-1789034400-1789041600@www.califesciences.org
SUMMARY:Navigating Regulatory Pathways for Health Innovation
DESCRIPTION:Demystify your regulatory pathway with this essential session: \n\nUnderstand the role of regulatory agencies like FDA and Health Canada in ensuring product safety and efficacy.\nDefine your solution’s classification and intended use to chart a clear regulatory pathway.\nLearn strategies for leveraging predicate devices and exploring 510(k) and De Novo submissions.\nNavigate global market entry requirements and compliance frameworks.\nDevelop a proactive regulatory strategy to minimize barriers and align with business goals.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/navigating-regulatory-pathways-for-health-innovation/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260909T160000
DTEND;TZID=America/Los_Angeles:20260909T180000
DTSTAMP:20260827T210647Z
CREATED:20260827T210647Z
LAST-MODIFIED:20260827T210647Z
UID:10001176-1788969600-1788976800@www.califesciences.org
SUMMARY:SheConnects
DESCRIPTION:Join Aquillius for SheConnects\, a monthly gathering designed to bring together women from all walks of life who are eager to connect\, collaborate\, and grow. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/aquillius-sheconnects/
LOCATION:10918 Technology Pl. San Diego CA 92127\, 10918 Technology Pl.\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260909T113000
DTEND;TZID=America/Los_Angeles:20260909T180000
DTSTAMP:20260824T160656Z
CREATED:20260824T160656Z
LAST-MODIFIED:20260824T160656Z
UID:10001170-1788953400-1788976800@www.califesciences.org
SUMMARY:Bicoastal Medical Devices & Diagnostics Symposium
DESCRIPTION:Medical Device & Diagnostics 2026 is a premier bicoastal event that brings together innovators\, industry leaders\, healthcare professionals\, investors\, and entrepreneurs to shape the future of medical technology. Explore breakthrough medical devices\, cutting-edge diagnostics\, and emerging technologies through inspiring keynotes\, expert panel discussions\, and meaningful networking opportunities. \nHosted on both the East and West Coasts\, this event offers greater accessibility while delivering the same world-class content and collaborative experience at each location. Whether you join us in Baltimore or San Diego\, you’ll connect with the minds driving innovation\, gain actionable insights into regulatory and market trends\, and discover the partnerships that will define the next generation of healthcare. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bicoastal-medical-devices-diagnostics-symposium/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260908T140000
DTEND;TZID=America/Los_Angeles:20260908T150000
DTSTAMP:20260824T155308Z
CREATED:20260824T155308Z
LAST-MODIFIED:20260824T155308Z
UID:10001167-1788876000-1788879600@www.califesciences.org
SUMMARY:The Massive Scale of GLP-1s: Evolving Health\, Healthcare and Markets
DESCRIPTION:GLP-1 receptor agonists. Never before has one therapeutic class promised such a seismic shift in the health of Americans—or the U.S. and global economies. Already established as cornerstone therapies in diabetes and obesity\, Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide bring in billions of dollars each year. And the drugs are only expanding their reach: semaglutide has also been approved to lower cardiovascular risk and tirzepatide for sleep apnea\, with ongoing research showing promise in treating conditions as far afield as addiction\, Alzheimer’s disease and cancer. \nSo it’s no wonder the class is having a larger\, structural effect on U.S. health systems and consumer markets\, from a rise in direct-to-consumer purchasing options to debates over pricing and coverage. How can companies—both established providers of GLP-1s and those looking to break onto the exploding market—navigate this unprecedented territory? What will it mean for patients? \nThis panel will focus on understanding how the incredible health gains driven by GLP-1s can reach as many people as possible and how these drugs might evolve the broader healthcare system. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-massive-scale-of-glp-1s-biospace/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-massive-scale-of-glp-1s-biospace/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T163000
DTEND;TZID=America/Los_Angeles:20260902T180000
DTSTAMP:20260827T204555Z
CREATED:20260827T204555Z
LAST-MODIFIED:20260827T204555Z
UID:10001174-1788366600-1788372000@www.califesciences.org
SUMMARY:Fragrance: The Invisible Signature
DESCRIPTION:A panel discussion exploring the art and science of fragrance\, how biology shapes what we smell\, and where new opportunities are for personalized wellness. \nCreated exclusively for this event: Guest perfumer Albert Ching will unveil an original fragrance\, share the thinking and creative process behind its design\, and invite guests to experience a selection of new scents. Join scientists\, founders\, investors\, creators\, and fragrance enthusiasts for an experiential salon. \nWe’ll explore: \n\nHow fragrance is made & the rise of niche brands\nHow GLP-1s\, stress\, hormones\, and aging may change our preferences\nHow wellness and lifestyle trends are reshaping consumer choices\nWhere founders and investors see real opportunity—and what may be hype\n\nPanelists\nAlbert Ching — Founder\, Maison Buongiorno\nIndependent bespoke perfumer creating deeply personal fragrances through olfactory craft\, technology\, and storytelling. \nChristina Loff — The Dry Down Diaries\nFragrance writer\, critic\, and independent-artist advocate bringing a sharp perspective on scent\, culture\, creativity\, and the changing consumer. \nJonathan Moustakis\, M.D. — CTO and Co-founder\, Lume Health\nPhysician and tech founder developing wearable biosensors to reveal how hormones\, stress\, and circadian rhythms shape health. \nMichele Colucci\, Esq. — Managing Partner\, DigitalDx Ventures\nLawyer\, serial entrepreneur and venture investor backing emerging technologies across diagnostics\, longevity\, and consumer wellness. \nHosted and moderated by Helen Chen\, PhD\nMolecular biologist\, co-founder of Alixia\, developing new therapeutics for treating cancer & aging. \nProgram\n4:20–4:30 pm — Arrival & Sensory Prelude\nSettle in and experience the salon’s opening sensory installation—before its story is revealed. \n4:30–5:20 pm — Panel Conversation\, audience Q&A\nExplore the science\, art\, and innovation of fragrance—and its evolving relationship with health\, wellness\, technology\, and consumer behavior. \n5:20–5:30 pm — The Fragrance Revealed\nAlbert Ching unveils the original fragrance created exclusively for the salon and shares its creative process and design concept. \n5:30–6:00 pm — Scent Discovery & Conversation\nExperience selected fragrances\, meet the speakers\, and continue the conversation. \nCome curious—and bring your questions: \n\nWhat new scents could express my personal or professional identity?\nWhat can biometrics reveal about our wellness?\nWhere are fragrance and wellness headed next?\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/fragrance-the-invisible-signature/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T110000
DTEND;TZID=America/Los_Angeles:20260902T120000
DTSTAMP:20260827T204029Z
CREATED:20260827T204029Z
LAST-MODIFIED:20260827T204029Z
UID:10001173-1788346800-1788350400@www.califesciences.org
SUMMARY:PEO Educational Webinar 101
DESCRIPTION:For startups and high-growth companies\, scaling the business often means adding employees\, entering new states\, competing for talent\, and managing increasingly complex HR requirements—all before there is a need or budget for a large internal HR team. A PEO can provide the infrastructure to support that growth by bringing together payroll\, benefits\, HR technology\, compliance support\, workers’ compensation\, and HR expertise under one model. This allows leadership to stay focused on growing the business while creating a more sophisticated employee experience earlier in the company’s lifecycle. Just as importantly\, choosing the right PEO creates a foundation that can scale with the organization\, helping reduce administrative burden\, manage risk\, and avoid having to rebuild HR processes every time the company reaches its next stage of growth. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/peo-educational-webinar-101/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/peo-educational-webinar-101/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T070000
DTEND;TZID=America/Los_Angeles:20260902T080000
DTSTAMP:20260820T212048Z
CREATED:20260820T212048Z
LAST-MODIFIED:20260820T212048Z
UID:10001164-1788332400-1788336000@www.califesciences.org
SUMMARY:Accelerating Pre-Clinical Large-Molecule Screening with an Integrated DMPK/ADME Approach
DESCRIPTION:In early discovery and development\, accurate bioanalytical methods\, combined with CMC manufacturability\, are essential for driving molecule screening and assessing developability within a DMPK/ADME framework. \nIn this webinar\, BioDuro will present case studies spanning multiple novel modalities including antibodies\, bispecific antibodies\, ADC (Antibody Drug Conjugate)\, and APC (Antibody Peptide Conjugate) therapeutics. The presentation will focus on three key areas: \n\nLC-MS/MS\, ELISA\, and Gyrolab as comparable bioanalytical methods for ADC and antibody PK analysis\nTransgenic mouse PK as a rapid screening approach\nADME screening strategies for peptides\, linkers\, and payloads in ADC programs.\n\nThese case studies demonstrate how an integrated DMPK/ADME platform can accelerate preclinical screening and improve decision-making for early-stage large-molecule programs. While bioanalysis of biologics and conjugated therapeutics presents unique challenges due to matrix complexity\, molecular heterogeneity\, and evolving analytical requirements\, innovative bioanalytical strategies can generate robust\, reliable data that enable confident candidate selection and successful program progression. \nWhat you will learn: \n\nUnderstand the strengths and applications of LC-MS/MS\, ELISA\, and Gyrolab for consistent pharmacokinetic analysis of antibodies and ADC\nLearn how transgenic mouse pharmacokinetic models can serve as a rapid and efficient approach for early candidate screening\nExplore ADME screening strategies for peptides\, linkers\, and payloads to support the discovery and optimization of ADC programs\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260728T183123Z
CREATED:20260728T183123Z
LAST-MODIFIED:20260728T183123Z
UID:10001138-1788220800-1788393599@www.califesciences.org
SUMMARY:Hub and Specialty Pharmacy Models West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite. \n\nCLS members receive a 10% discount to attend the conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/hub-and-specialty-pharmacy-models-west/
LOCATION:Estancia La Jolla Hotel & Spa\, 9700 N Torrey Pines Rd\, La Jolla\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T120000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260730T164058Z
CREATED:20260730T164058Z
LAST-MODIFIED:20260730T164058Z
UID:10001140-1787832000-1787835600@www.califesciences.org
SUMMARY:Genetically Engineered Mouse Models & Their Applications
DESCRIPTION:Genetically engineered mouse models (GEMMs) are the backbone of modern preclinical drug development. With the world’s largest GEMM repository and a fully integrated CRO platform\, GemPharmatech offers researchers an unmatched toolkit for moving from target biology to IND-enabling studies. \nIn this lunch and learn\, Jun Wang\, PhD\, Senior Scientific Director at GemPharmatech\, walks through real preclinical case studies across oncology\, metabolic disease\, neurology\, and immunology — illustrating how model selection\, study design\, and integrated CRO capabilities translate into more translatable data and more defensible go/no-go decisions. \nSpeaker Info\nJun Wang\, PhD \nSenior Scientific Director \nDr. Jun Wang has over 15 years of experience in biomedical research. Prior to joining GemPharmatech\, he served as an Associate Director of Research at Explora Biolabs/Charles River. He has extensive experience with genetically engineered mouse models for drug discovery in various therapeutic areas. Dr. Wang holds a Ph.D. in Developmental Neurobiology from the City of Hope and received his postdoctoral training in pediatric brain cancer research from the Sanford Burnham Prebys Medical Discovery Institute. \nAgenda\n\n​12:00 PM- 12:15 PM: Welcome – Lunch\n12:15- 1:00: Discussion\n​1:00 PM – 2:00 PM: Office Hours\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/genetically-engineered-mouse-models-their-applications/
LOCATION:5270 California Ave\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T083000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260727T194001Z
CREATED:20260727T193946Z
LAST-MODIFIED:20260727T194001Z
UID:10001132-1787819400-1787835600@www.califesciences.org
SUMMARY:Advances in Neuropsychiatry: Emerging Biology and Therapeutics
DESCRIPTION:The Frontiers in Neuropsych Symposium is a fully virtual event highlighting the latest advances in novel neuroscience therapeutics. The symposium brings together experts from across the field to examine innovative approaches to complex neuropsychiatric disorders\, spanning early biological discovery through clinical development. \nDesigned for scientists\, clinicians\, and industry leaders\, the event provides a forum for discussing emerging research and therapies that address significant unmet needs and aim to improve patient outcomes worldwide. \nKey Topics:\n\nBiomarker- and genomics-guided drug discovery in schizophrenia\nMental illness and PTSD\nDevelopmental and rare disorders associated with psychosis\nSleep\, behavioral wellness\, and recovery\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260826T170000
DTEND;TZID=America/Los_Angeles:20260826T193000
DTSTAMP:20260803T161233Z
CREATED:20260803T161233Z
LAST-MODIFIED:20260803T161233Z
UID:10001142-1787763600-1787772600@www.califesciences.org
SUMMARY:Build or Buy?: Evaluating AI Vendors and Tools for Life Sciences
DESCRIPTION:This is a 90-minute session for life sciences professionals who keep ending up in vendor demos without the right questions to ask. We’ll cover the three categories of AI tools showing up in your field right now\, and the five questions that reveal what any vendor claim is actually saying and what it isn’t. \n​The session ends with a workshop: vendor pitches\, applied framework\, written output. You’ll leave knowing exactly what to ask the next time someone puts a demo in front of you. \n​No prior technical background needed. \n​Who this is for: Operation leads\, IT heads\, R&D professionals\, regulatory and clinical teams\, and anyone in life sciences who evaluates\, recommends\, or works alongside AI tools. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/evaluating-ai-vendors-and-tools-for-life-sciences/
LOCATION:Kilroy Oyster Point\, 357 Oyster Point Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260821T080000
DTEND;TZID=America/Los_Angeles:20260821T090000
DTSTAMP:20260803T161501Z
CREATED:20260803T161501Z
LAST-MODIFIED:20260803T161501Z
UID:10001143-1787299200-1787302800@www.califesciences.org
SUMMARY:AI x Life Sciences - August Current Events
DESCRIPTION:KAMI Think Tank will be chatting about new announcements in the AI x Life Sciences world\, what new AI advancements have come through in the last month\, and so much more. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/ai-x-life-sciences-august-current-events/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/ai-x-life-sciences-august-current-events/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260819
DTEND;VALUE=DATE:20260821
DTSTAMP:20260720T170818Z
CREATED:20260720T170818Z
LAST-MODIFIED:20260720T170818Z
UID:10001129-1787097600-1787270399@www.califesciences.org
SUMMARY:Advances in Cancer Therapeutics
DESCRIPTION:Speakers: \nEric Blouin\, BHSci (Ipsos); Zhengping Wang\, PhD (Revolution Medicines); Pete Smith\, PhD (Remix Therapeutics); Matt Lorenzi\, PhD (Agni Bio); Jennifer Towne\, PhD (Vir Biotechnology); Scott McClellan\, MD\, PhD (Orca Bio); Jack West\, MD (Summit Therapeutics); Jonathan Yingling\, PhD (Arcus Bioscience); Jimmy Zhao\, MD\, PhD (Systimmune)\nOrganizers: \nToby Freedman (Synapsis Search Recruiting and Author)\, Joe Carlino (Carlino Consulting)\, Donald McCarthy (Dawn Biopharma)\, Betty Chang (Summit Therapeutics)\, Wenfeng Xu (Chantibody Therapeutics)\, Snow Ge (BridgeBio Pharma)\, Shichang Miao (PBSS) \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/advances-in-cancer-therapeutics/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advances-in-cancer-therapeutics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T150000
DTEND;TZID=America/Los_Angeles:20260818T170000
DTSTAMP:20260727T195232Z
CREATED:20260727T195232Z
LAST-MODIFIED:20260727T195232Z
UID:10001135-1787065200-1787072400@www.califesciences.org
SUMMARY:Revvity Drug Discovery Mixer: Science\, Posters & Cocktails
DESCRIPTION:Join us for an evening of science\, networking\, and cocktails at MBC Biolabs! Explore Revvity solutions for drug discovery\, engage with scientific posters\, and connect with fellow researchers while enjoying some refreshments. \nWe welcome poster presentations! If you’d like to share your work\, please contact Estelle N’garwate at Estelle.Ngarwate@revvity.com. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/revvity-drug-discovery-mixer/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T100000
DTEND;TZID=America/Los_Angeles:20260818T110000
DTSTAMP:20260716T163026Z
CREATED:20260716T163026Z
LAST-MODIFIED:20260716T163026Z
UID:10001127-1787047200-1787050800@www.califesciences.org
SUMMARY:Target Biology and Modality Selection Strategies in Prostate Cancer Therapeutics
DESCRIPTION:Join this webinar to explore how target biology\, tumor heterogeneity\, and lineage evolution influence target and modality selection\, with insights from representative targets including PSMA\, B7-H3\, STEAP1\, KLK2\, and DLL3. \nKey Highlights: \n\nUnderstand the role of target biology in prostate cancer drug development.\nExplore how tumor heterogeneity and lineage evolution impact target selection.\nLearn how target characteristics guide modality selection\, including ADCs and T-cell engagers (TCEs).\nReview the latest development strategies for emerging targets such as PSMA\, B7-H3\, STEAP1\, KLK2\, and DLL3.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/target-biology-strategies-in-prostate-cancer-therapeutics/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/target-biology-strategies-in-prostate-cancer-therapeutics/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260814
DTEND;VALUE=DATE:20260816
DTSTAMP:20260722T190841Z
CREATED:20260722T190841Z
LAST-MODIFIED:20260722T190841Z
UID:10001130-1786665600-1786838399@www.califesciences.org
SUMMARY:Legends of Science and Surfing
DESCRIPTION:For the second year\, Legends of Science and Surfing brings together leaders from academia\, biotechnology\, industry and the investment community to explore the future of cancer research and care. Hosted by Moores Cancer Center at UC San Diego Health\, the two-day event begins with the Legends of Science Oncology Symposium on Friday\, August 14\, featuring keynote speaker Kevan M. Shokat\, PhD\, alongside renowned experts discussing breakthroughs in precision oncology\, AI\, drug discovery and next-generation clinical trials. \nOn Saturday\, August 15\, the tradition continues with the 33rd Annual Legends of Surfing Invitational\, bringing together world-class surfers\, scientists\, cancer survivors and supporters to raise critical funds for groundbreaking cancer research and compassionate patient care. Together\, these events celebrate innovation\, collaboration and a shared commitment to advancing the future of cancer medicine. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/legends-of-science-and-surfing/
LOCATION:8606 Kennel Way\, 8606 Kennel Way\, La Jolla\, CA\, 92093\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260806T120000
DTEND;TZID=America/Los_Angeles:20260806T130000
DTSTAMP:20260727T195002Z
CREATED:20260727T195002Z
LAST-MODIFIED:20260727T195002Z
UID:10001134-1786017600-1786021200@www.califesciences.org
SUMMARY:Withum Tax Lunch & Learn: Maximizing Tax Incentives for Growth-Stage Life Sciences Companies
DESCRIPTION:Join Withum’s tax specialists for an insightful Lunch & Learn focused on two of the most valuable tax incentives available to emerging and high-growth life sciences companies: Qualified Small Business Stock (QSBS) and the Research & Development (R&D) Tax Credit. \nWhether you’re developing groundbreaking technologies\, raising capital\, or planning for future liquidity events\, understanding these incentives can have a significant impact on your company’s growth strategy and long-term value. Learn how early-stage decisions around entity structure\, equity issuance\, and compliance can help preserve valuable QSBS benefits that may allow shareholders to exclude up to 100% of eligible capital gains. We’ll also explore how companies can leverage the R&D Tax Credit to offset federal tax liabilities—or even generate immediate cash flow benefits through payroll tax offsets of up to $500\,000 annually. \nDuring this interactive session\, you’ll gain practical insights into: \n\nMaximizing QSBS opportunities through proactive planning and structuring\nCommon pitfalls that can jeopardize valuable tax benefits\nIdentifying qualifying R&D activities and expenses\nMonetizing R&D credits even when operating at a loss\nTax strategies that help fuel innovation\, growth\, and investor value\n\nEnjoy lunch\, connect with fellow innovators and walk away with actionable strategies that could help your company reduce taxes\, improve cash flow and position itself for long-term success. \nWho Should Attend: Founders\, CEOs\, CFOs\, finance leaders\, investors and life sciences professionals interested in optimizing tax incentives and enhancing enterprise value. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/withum-tax-lunch-learn/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260805T170000
DTEND;TZID=America/Los_Angeles:20260805T203000
DTSTAMP:20260727T193721Z
CREATED:20260727T193721Z
LAST-MODIFIED:20260727T193721Z
UID:10001131-1785949200-1785961800@www.califesciences.org
SUMMARY:Sierra Nights
DESCRIPTION:The future of science is outsourcing. In this Sierra Nights\, we will explore how biotech startups can work effectively with CROs and CRDMOs\, from choosing the right partner to designing studies\, managing timelines\, interpreting data\, and avoiding common outsourcing mistakes. \n​A CRO\, or Contract Research Organization\, is an external company that provides specialized research services to biotech and pharmaceutical companies\, including assay development\, preclinical studies\, toxicology\, pharmacology\, formulation\, manufacturing support\, clinical trial operations\, and more. \n​The evening will include a panel of biotech leaders who have worked with CROs across different stages of company building and drug development. They will share practical lessons on what worked\, what went wrong\, how to communicate expectations\, and how to turn outsourced experiments into decision-ready data. \n​The event will also include participation from CRO sponsors\, giving founders a chance to meet service providers\, ask questions\, and better understand how to evaluate potential partners. \n​5:00 – 6:00pm: Doors Open and Networking\n​6:00 – 6:15: Host & Sponsors Introductions\n​6:15 – 7:30pm: Panel Discussions\n​7:30 – 9:00: Reception\, Music\, and Networking \nFounder and CRO Panelists:\n​Leah Makley\, PhD\, is Chief Operating Officer of MBC BioLabs\, the Bay Area’s largest life sciences incubator supporting 200+ biotech startups across five sites. She brings over a decade of firsthand experience managing CRO relationships as a startup founder or executive: she co-founded and led ViewPoint Therapeutics\, developing novel small molecule therapeutics in ophthalmology as a virtual\, venture-backed company with a small team of 16. She later served as COO of Deciduous Therapeutics\, and is now building Ocutheia\, a new ophthalmology company advancing a novel small molecule therapeutic on a primarily virtual basis. Across all three\, Leah has relied on CRO partners\, giving her a founder’s-eye view of what it takes to manage quality\, timelines\, and budget through those relationships. Leah holds a PhD in medicinal chemistry from the University of Michigan.\n​\n​Stephen Floor\, PhD\, is the Head of Biology at Marigold Bio where he uses AI and scalable experiments to advance genetic medicines. In his current role\, Stephen actively identifies\, contacts\, negotiates with\, evaluates\, and executes research plans with CROs spanning diverse research domains. He formerly led R&D and strategy work at Inceptive using generative AI to design mRNA therapeutics. Prior to Inceptive\, Stephen was a professor at the University of California\, San Francisco studying RNA regulation in human cells and how it is altered in cancers and developmental disorders. Stephen has deep experience managing distributed teams and CROs in academic and biotech environments\, including working across timezones and continents – and the challenges and opportunities that creates experimentally and logistically. Stephen received his PhD in Biophysics from UCSF.\n​\n​Debanu Das\, PhD\, is the Co-Founder and CEO of Accelero Biostructures and Co-Founder of XPose Therapeutics\, where he pioneered a structure-first approach to drugging traditionally “undruggable” targets\, using 3D crystal structures of small molecules bound to DNA Damage Response (DDR) proteins to generate novel therapeutic leads. This DDR-focused pipeline supports multiple treatment strategies\, including enzyme inhibition\, synthetic lethality\, and targeted-protein degradation. XPose’s discovery was powered by Accelero’s high-throughput protein X-ray crystallography platforms\, which enabled rapid fragment screening and iterative\, structure-guided optimization of hit compounds. In 2026\, XPose was acquired by Mid-Atlantic BioTherapeutics (MABT). Debanu joined MABT’s leadership team as part of the acquisition\, bringing over 20 years of expertise in structural biology\, drug discovery and outsourced R&D with CROs. Debanu holds a PhD from Rutgers-The State University of New Jersey\, New Brunswick\, and an Integrated MS from the Indian Institute of Technology\, Kanpur.\n​\n​Will DeLoache is co-founder and CEO of Tabulous\, a data platform for life sciences R&D teams. Previously\, he co-founded Novome Biotechnologies\, a South San Francisco company engineering bacterial therapeutics for chronic disease\, where he served as CEO and later CSO. During his tenure\, Novome advanced its programs from early-stage research through Phase 2 clinical trials and established a therapeutic partnership with Genentech\, working with CROs and CDMOs across preclinical\, manufacturing\, and clinical development. He holds a PhD in Bioengineering from UC Berkeley and a BS in Biology from Davidson College. \n​Sponsors: WuXi Biologics\, Transpharmation\, Clutch Bio \n​Who should apply\nPeople building or operating in biotech and related life science workflows. \n​About Sierra Nights\nSierra Nights is an event series for the parts of biotech that don’t show up on slides. The gaps people are dealing with\, the tools they’re actually using\, and the signals worth paying attention to. \n​About MBC BioLabs\nMBC BioLabs\, flexible lab-space for ambitious biotech companies tackling today’s biggest challenges. Learn more at www.mbcbiolabs.com \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/sierra-nights/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260805T100000
DTEND;TZID=America/New_York:20260805T130000
DTSTAMP:20260615T163827Z
CREATED:20260615T163827Z
LAST-MODIFIED:20260615T163827Z
UID:10001106-1785924000-1785934800@www.califesciences.org
SUMMARY:Endpoints Manufacturing Day 2026
DESCRIPTION:Most large drugmakers have navigated through the Trump administration’s tariff quagmire\, but the waters are still choppy for the biopharma industry. How has the biopharma world metabolized and adjusted over the past year and what new trends in manufacturing and logistics are on the horizon? Join Endpoints to hear expert takes on the landscape. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/endpoints-manufacturing-day-2026/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/endpoints-manufacturing-day-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260730T083000
DTEND;TZID=America/Los_Angeles:20260730T100000
DTSTAMP:20260615T164620Z
CREATED:20260615T164620Z
LAST-MODIFIED:20260615T164620Z
UID:10001108-1785400200-1785405600@www.califesciences.org
SUMMARY:Peptides\, Proximity\, and Precision: The Expanding Druggable Proteome
DESCRIPTION:Drug discovery is ever-evolving with simultaneous advances in modality\, mechanism\, and druggable landscape. The assets entering the clinic in 2025 mark a genuine striking point across multiple fronts. A modality once confined to injectables is routinely going oral\, expanding opportunities to indications long reserved for biologics. Induced-proximity and ternary complex-stabilization mechanisms have progressed from preclinical concepts to established pipeline strategies\, disarming targets that resisted decades of pursuit via traditional approaches. Mature target classes are yielding first- and best-in-class assets as advances in selectivity\, binding kinetics\, and molecule design catch up to the underlying biology. And the oldest drug target family is having a second act\, with structure-enabled design unlocking therapeutic opportunities few expected to unfold. This talk highlights ten recent programs across macrocyclic peptides\, Class B GPCRs\, functionally-differentiated small molecules\, and proximity pharmacology\, highlighting the chemical matter\, target biology\, and design strategies that distinguish them and what insights/lessons discovery teams can leverage. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/peptides-proximity-and-precision-the-expanding-druggable-proteome/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/peptides-proximity-and-precision-the-expanding-druggable-proteome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T090000
DTEND;TZID=America/Los_Angeles:20260729T100000
DTSTAMP:20260611T234345Z
CREATED:20260611T234345Z
LAST-MODIFIED:20260611T234345Z
UID:10001104-1785315600-1785319200@www.califesciences.org
SUMMARY:Footprints Without Footwork: Automated Benchtop HRPF for Binding Partners and Interfaces
DESCRIPTION:About this Webinar\nEvery protein leaves a footprint — the surface-exposed side chains that are accessible when it folds\, when it binds\, when it changes shape. Hydroxyl radical protein footprinting (HRPF) reads those footprints by oxidising the exposed residues and leaving the buried ones alone — a structural mass spectrometry technique that runs on standard laboratory equipment plus a benchtop Fenton reaction. Done by hand it is labor-intensive: multiple radical concentrations\, replicate reactions\, and dose-response curves that are sensitive to pipetting variability. Manual HRPF also limits the technique in scope — applying it across the dozens of pulldowns needed to characterise a complex becomes impractical. \nIn this webinar we show how moving the workflow onto the Opentrons Flex liquid handler tightens reproducibility and lifts throughput\, and how applying that automated workflow to affinity-purified protein complexes lets you identify binding partners and map their interaction interfaces in the same experiment. \nWhat you’ll learn in this webinar:\n\nHRPF can be performed using standard laboratory equipment to probe surface-accessible amino acids on proteins and protein complexes\nAutomating HRPF reactions on the Opentrons Flex reduces variability and increases throughput\nPerforming HRPF reactions on affinity-purified protein complexes can provide insights into binding partners and interfaces simultaneously\n\nOur Speaker:\nTyler Cropley is a Research Scientist in the Proteomics Laboratory at NYU Langone Health under the supervision of Dr. Beatrix Ueberheide. His work focuses on using mass spectrometry-based methods to study higher-order protein structure. He earned his PhD from Florida State University under the supervision of Dr. Christian Bleiholder. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/nyu-footprint-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/nyu-footprint-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260728T120000
DTEND;TZID=America/Los_Angeles:20260728T130000
DTSTAMP:20260709T155908Z
CREATED:20260709T155908Z
LAST-MODIFIED:20260709T155908Z
UID:10001123-1785240000-1785243600@www.califesciences.org
SUMMARY:Built to Scale\, Positioned to Sell: Navigating MedTech Manufacturing Readiness and M&A
DESCRIPTION:Manufacturing readiness is one of the clearest signals of whether a MedTech company is truly built to scale—and ultimately\, to sell. For early-stage life science and medical device ventures\, initial decisions around product design\, quality systems\, and supply chain planning can either accelerate commercialization or create devastating\, costly barriers to an exit. \n​Presented by PDV MedTech\, and University Lab Partners\, this panel brings together the vital pillars of the MedTech ecosystem: investment banking\, advanced manufacturing leadership\, and venture acceleration. Together\, our experts will explore how operational readiness directly impacts valuation\, investor confidence\, and M&A diligence outcomes. Attendees will gain actionable insights into bridging the gap between clinical validation and commercial scalability\, minimizing technical debt\, and making strategic choices today that maximize optionality and exit value tomorrow. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/navigating-medtech-manufacturing-readiness-and-ma/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/navigating-medtech-manufacturing-readiness-and-ma/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260723T160000
DTEND;TZID=America/Los_Angeles:20260723T180000
DTSTAMP:20260716T163344Z
CREATED:20260716T163344Z
LAST-MODIFIED:20260716T163344Z
UID:10001128-1784822400-1784829600@www.califesciences.org
SUMMARY:VRP Labs Summer Happy Hour
DESCRIPTION:Join us at Valley Research Park for a Summer Happy Hour! Connect with others in the biotech startup community\, enjoy appetizers and drinks\, and join in on the summer fun. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vrp-labs-summer-happy-hour/
LOCATION:Valley Research Park\, 319 N. Bernardo Avenue\, Mountain View\, CA\, 94043\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T140000
DTEND;TZID=America/Los_Angeles:20260722T150000
DTSTAMP:20260610T174519Z
CREATED:20260610T174519Z
LAST-MODIFIED:20260610T174519Z
UID:10001102-1784728800-1784732400@www.califesciences.org
SUMMARY:From Clinical to Commercial: Talent Strategies for Biopharma Growth
DESCRIPTION:Early indications in 2026 are pointing towards a slight recovery in the biopharma job market. Join industry hiring experts for a data-informed discussion on where the life sciences job market stands today\, what trends we are witnessing in hiring and how hiring managers and HR and talent acquisition professionals can navigate shifts towards commercial readiness and/or building out commercial teams. \nThis webinar will provide a clear-eyed assessment of current hiring conditions across biopharma\, exploring how the economic climate is impacting workforce development and how hiring practices are evolving as organizations prepare to take products to market. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T120000
DTEND;TZID=America/Los_Angeles:20260722T130000
DTSTAMP:20260709T155653Z
CREATED:20260709T155653Z
LAST-MODIFIED:20260709T155653Z
UID:10001122-1784721600-1784725200@www.califesciences.org
SUMMARY:How to Evaluate if the Model Actually Works
DESCRIPTION:Every AI tool arrives with an impressive number attached. The number is usually real but whether it means anything is another matter. \n​This 60-minute session teaches life-sciences researchers and managers how to evaluate a performance claim for AI models. We open with a model that scored well in its own hospital but fell apart in the next one. You’ll leave with a five-question checklist that exposes a weak claim in a few minutes. \n​The session ends with a hands-on exercise where we examine two models and decide which to deploy. \n​Who this is for: Life science professionals\, managers\, researchers\, and anyone in life sciences who is looking to evaluate AI tools. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-evaluate-if-the-model-actually-works/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-evaluate-if-the-model-actually-works/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T090000
DTEND;TZID=America/Los_Angeles:20260722T100000
DTSTAMP:20260611T234114Z
CREATED:20260611T234114Z
LAST-MODIFIED:20260611T234114Z
UID:10001103-1784710800-1784714400@www.califesciences.org
SUMMARY:A Hybrid Fragmentation Strategy for Modified Oligos
DESCRIPTION:About this webinar\nMass-spectrometric sequencing of therapeutic oligonucleotides is constrained by the choice of fragmentation method. Electron-transfer dissociation (ETD) struggles to fully fragment modified backbones — particularly locked nucleic acids (LNA) — and higher-energy collisional dissociation (HCD) produces dense spectra that are slow to interpret and prone to coverage gaps. For antisense oligos that combine LNA modifications with phosphorothioate (PS) backbones\, neither approach on its own delivers reliable end-to-end coverage. \nThis webinar presents a hybrid fragmentation approach that combines ETD and HCD in a single Orbitrap scan (EThcD)\, applied across a panel of 16-mer modified oligonucleotides — LNA-containing antisense oligos\, full PS and PO backbones\, and PS/PO mixtures. The method gives full sequence coverage from w-ions alone\, with cleaner spectra than HCD and a controlled\, a/w- and d/z-dominant fragment pattern suitable for automated assignment in Byos. Kevin will also walk through the Byos processing recipe used to interpret the data and the optimal EThcD energy identified for the 16-mer panel. \nKey Takeaways\n\nA single Orbitrap scan that covers modified oligos end-to-end. EThcD on highly-charged anionic precursors yields full w-ion coverage on LNA-containing antisense oligonucleotides and PS-backbone samples where ETD and HCD alone leave gaps.\nA counter-intuitive PS-versus-PO finding. Phosphorothioate backbones fragment more efficiently under EThcD than phosphodiester backbones — with direct implications for impurity screening in PS therapeutics.\nA practical EThcD processing recipe in Byos. Recommended energy settings\, fragment-type configuration\, and a strict-then-lenient pass strategy for confident sequence coverage and impurity detection.\n\nSpeaker\nKevin Hes — PhD candidate\, Division of BioAnalytical Chemistry & MS-LaserLab\, Vrije Universiteit Amsterdam. PhD jointly sponsored by AstraZeneca\, GSK\, and Novartis\, with funding from the Dutch Research Council (NWO); co-supervised by Anouk Rijs and Govert Somsen. Part of the InnovATOR consortium InnovATOR consortium. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
END:VEVENT
END:VCALENDAR